|
pSS |
HC |
Number |
31 |
29 |
Age(years) |
47.13±11.94 |
43.69±8.79 |
Female,n(%) |
29(93.55%) |
28(96.55%) |
Male,n(%) |
2(6.45%) |
1(3.45%) |
Disease duration(months) |
46(1-122) |
NA |
Major clinical features |
|
|
Dry mouth,n(%) |
24( 77.42%) |
NA |
Dry eye,n(%) |
15(48.39%) |
NA |
Decayed tooth,n(%) |
11(35.48%) |
NA |
Glandular swelling,n(%) |
5(16.13%) |
NA |
Raynaud’s phenomenon,n(%) |
3(9.68%) |
NA |
Fatigue,n(%) |
15(48.39%) |
NA |
Weigh loss,n(%) |
1(3.23%) |
NA |
Arthralgia,n(%) |
9(29.03%) |
NA |
Skin involvement,n(%) |
6(19.35%) |
NA |
Primary biliary cirrhosis,n(%) |
5(16.13%) |
NA |
Renal involvement,n(%) |
4(12.90%) |
NA |
Interstitial lung disease,n(%) |
11(35.48%) |
NA |
Fever,n(%) |
1(3.23%) |
NA |
Muscle involvement,n(%) |
1(3.23%) |
NA |
Nervous system involvement,n(%) |
1(3.23%) |
NA |
High-IgG |
20(64.52%) |
NA |
Leukocytopenia |
5(16.13%) |
NA |
Major laboratory features |
|
|
ESR(mm/h) |
14.50(2.00-62.00) |
NA |
CRP(mg/L) |
1.76(0.20-8.91) |
NA |
RF(IU/ml) |
46.20(20.00-777.00) |
NA |
WBC(×109/L) |
4.72(2.79-11.78) |
NA |
Lymphocyte(×109/L) |
1.55±0.60 |
NA |
NC(×109/L) |
2.69(1.44-8.74) |
NA |
RBC(×1012/L) |
4.23±0.38 |
NA |
Hb(g/L) |
126±11.26 |
NA |
Plt(×109/L) |
203.80±49.31 |
NA |
Serum globulin(g/L) |
31.70±6.13 |
NA |
IgG(g/L) |
17.84±5.01 |
NA |
IgA(g/L) |
2.77(1.40-10.60) |
NA |
IgM(g/L) |
1.16(0.41-7.35) |
NA |
C3(g/L) |
0.79 (0.62-1.52) |
NA |
C4(g/L) |
0.19±0.06 |
NA |
Anti-SSA/Ro52 (+) ,n(%) |
28(90.32%) |
NA |
Anti-SSA/Ro60 (+),n(%) |
24(77.42%) |
NA |
Anti-SSB(+),n(%) |
20(64.52%) |
NA |
Anti-centromere(+),n(%) |
3(9.68%) |
NA |
ESSDAI |
3.00(1.00-8.00) |
NA |
ESSPRI |
3.00(1.33-5.00) |
NA |
ILD: Interstitial lung disease , PBC:Primary biliary cirrhosis
ESR:Erythrocyte Sedimentation Rate,
|
ILD: Interstitial lung disease , PBC:Primary biliary cirrhosis
ESR:Erythrocyte Sedimentation Rate,
|
ILD: Interstitial lung disease , PBC:Primary biliary cirrhosis
ESR:Erythrocyte Sedimentation Rate,
|
RF: Rheumatoid Factor, CRP:C-Reactive Protein, WBC: White Blood Cell, |
RF: Rheumatoid Factor, CRP:C-Reactive Protein, WBC: White Blood Cell, |
RF: Rheumatoid Factor, CRP:C-Reactive Protein, WBC: White Blood
Cell, |
RBC: Red Blood Cell , Hb: Hemoglobin, Plt :Platelet, NC: Neutrophil
Cell, |
RBC: Red Blood Cell , Hb: Hemoglobin, Plt :Platelet, NC:
Neutrophil Cell, |
RBC: Red Blood Cell , Hb: Hemoglobin, Plt :Platelet,
NC: Neutrophil Cell, |
IgG: Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin M, |
IgG: Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin M, |
IgG: Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin
M, |
C3: Complement 3, C4: Complement 4, NA: Not Applicable, |
C3: Complement
3, C4: Complement 4, NA: Not Applicable, |
C3: Complement 3, C4:
Complement 4, NA: Not Applicable, |
ESSDAI:European League Against Rheumatism Sjogren’s Syndrome Disease
Activity Index, |
ESSDAI:European League Against Rheumatism Sjogren’s
Syndrome Disease Activity Index, |
ESSDAI:European League Against
Rheumatism Sjogren’s Syndrome Disease Activity Index, |
ESSPRI:European League Against Rheumatism Sjogren’s Syndrome Patient
Reported Index. |
ESSPRI:European League Against Rheumatism Sjogren’s
Syndrome Patient Reported Index. |
ESSPRI:European League Against
Rheumatism Sjogren’s Syndrome Patient Reported Index. |